About Aliada Therapeutics
Aliada Therapeutics is a company based in Boston (United States) founded in 2021 was acquired by AbbVie in October 2024.. Aliada Therapeutics has raised $33 million across 1 funding round from investors including AbbVie, RA Capital and Johnson & Johnson Innovation – JJDC. Aliada Therapeutics operates in a competitive market with competitors including WuXi AppTec, Eurofins Scientific, Ipsen, ANI Pharmaceuticals and Red Nucleus, among others.
- Headquarter Boston, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Unlock access to complete
Funding Insights of Aliada Therapeutics
Aliada Therapeutics has successfully raised a total of $33M through 1 strategic funding round. The most recent funding activity was a Seed round of $33 million completed in July 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Seed — $33.0M
-
First Round
First Round
(06 Jul 2021)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Seed - Aliada Therapeutics | Valuation | Johnson & Johnson Innovation – JJDC , RA Capital Management |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Aliada Therapeutics
Aliada Therapeutics has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include AbbVie, RA Capital and Johnson & Johnson Innovation – JJDC. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm backed by Johnson & Johnson
|
Founded Year | Domain | Location | |
|
RA Capital is engaged in evidence-based investing in healthcare and life sciences.
|
Founded Year | Domain | Location | |
|
Biopharmaceutical research and drug development are conducted globally by AbbVie.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Aliada Therapeutics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Aliada Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Aliada Therapeutics Comparisons
Competitors of Aliada Therapeutics
Aliada Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as WuXi AppTec, Eurofins Scientific, Ipsen, ANI Pharmaceuticals and Red Nucleus, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of CRO and CDMO services
|
|
| domain | founded_year | HQ Location |
Laboratory testing and contract research services are provided globally.
|
|
| domain | founded_year | HQ Location |
Biopharmaceutical company focused on developing and commercializing innovative treatments in oncology, rare disease, and neuroscience to improve patient health outcomes
|
|
| domain | founded_year | HQ Location |
Branded and generic prescription drugs are developed, manufactured, and marketed.
|
|
| domain | founded_year | HQ Location |
Advisory, scientific, and medical communications provided for pharmaceutical industry.
|
|
| domain | founded_year | HQ Location |
Regulatory support, brand differentiation, and prototyping services are provided.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Aliada Therapeutics
Frequently Asked Questions about Aliada Therapeutics
When was Aliada Therapeutics founded?
Aliada Therapeutics was founded in 2021.
Where is Aliada Therapeutics located?
Aliada Therapeutics is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
Is Aliada Therapeutics a funded company?
Aliada Therapeutics is a funded company, having raised a total of $33M across 1 funding round to date. The company's 1st funding round was a Seed of $33M, raised on Jul 06, 2021.
What does Aliada Therapeutics do?
Aliada Therapeutics, backed by 33000000.0 from Johnson Johnson Innovation JJDC, RA Capital Management, focuses on providing healthcare solutions, biopharma outsourcing, and diversified. Provider of drug research development services for multiple therapeutic areas. Driving innovation, growth, and excellence in its industry sectors.
Who are the top competitors of Aliada Therapeutics?
Aliada Therapeutics's top competitors include WuXi AppTec, ANI Pharmaceuticals and Aptar.
Who are Aliada Therapeutics's investors?
Aliada Therapeutics has 3 investors. Key investors include AbbVie, RA Capital, and Johnson & Johnson Innovation – JJDC.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.